Comments
Loading...

Ocular Therapeutix Analyst Ratings

OCULNASDAQ
Logo brought to you by Benzinga Data
$8.73
-0.22-2.46%
At close: -
$8.73
0.000.00%
After Hours: Jun 13, 4:36 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$22.00
Lowest Price Target1
$11.00
Consensus Price Target1
$16.33

Ocular Therapeutix Analyst Ratings and Price Targets | NASDAQ:OCUL | Benzinga

Ocular Therapeutix Inc has a consensus price target of $16.33 based on the ratings of 13 analysts. The high is $22 issued by Scotiabank on October 16, 2024. The low is $11 issued by TD Cowen on June 20, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Needham, and Needham on May 29, 2025, May 6, 2025, and April 8, 2025, respectively. With an average price target of $14.67 between HC Wainwright & Co., Needham, and Needham, there's an implied 68.00% upside for Ocular Therapeutix Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
3
Mar
2
Apr
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Needham
RBC Capital
Citizens Capital Markets
Scotiabank

1calculated from analyst ratings

Analyst Ratings for Ocular Therapeutix

Buy NowGet Alert
05/29/2025Buy Now71.82%HC Wainwright & Co.
Yi Chen61%
$15 → $15ReiteratesBuy → BuyGet Alert
05/06/2025Buy Now60.37%Needham
Serge Belanger70%
$15 → $14MaintainsBuyGet Alert
04/08/2025Buy Now—William Blair
Lachlan Brown38%
—Initiates → OutperformGet Alert
04/08/2025Buy Now71.82%Needham
Serge Belanger70%
$15 → $15ReiteratesBuy → BuyGet Alert
03/18/2025Buy Now94.73%RBC Capital
Luca Issi46%
→ $17Initiates → OutperformGet Alert
03/11/2025Buy Now71.82%Needham
Serge Belanger70%
→ $15Initiates → BuyGet Alert
03/04/2025Buy Now117.64%Citizens Capital Markets
Jonathan Wolleben72%
$22 → $19MaintainsMarket OutperformGet Alert
03/04/2025Buy Now71.82%HC Wainwright & Co.
Yi Chen61%
$15 → $15ReiteratesBuy → BuyGet Alert
12/03/2024Buy Now71.82%HC Wainwright & Co.
Yi Chen61%
$15 → $15ReiteratesBuy → BuyGet Alert
11/15/2024Buy Now71.82%HC Wainwright & Co.
Yi Chen61%
$14 → $15MaintainsBuyGet Alert
10/16/2024Buy Now152%Scotiabank
Greg Harrison48%
→ $22Initiates → Sector OutperformGet Alert
10/16/2024Buy Now60.37%HC Wainwright & Co.
Yi Chen61%
$14 → $14ReiteratesBuy → BuyGet Alert
08/08/2024Buy Now94.73%Baird
Colleen Kusy36%
$18 → $17MaintainsOutperformGet Alert
08/01/2024Buy Now60.37%HC Wainwright & Co.
Yi Chen61%
$14 → $14ReiteratesBuy → BuyGet Alert
06/21/2024Buy Now71.82%Piper Sandler
Biren Amin41%
$15 → $15MaintainsOverweightGet Alert
06/20/2024Buy Now26%TD Cowen
Tara Bancroft66%
$7 → $11UpgradeHold → BuyGet Alert
06/14/2024Buy Now71.82%Piper Sandler
Joseph Catanzaro46%
$15 → $15MaintainsOverweightGet Alert
06/14/2024Buy Now60.37%HC Wainwright & Co.
Yi Chen61%
$14 → $14ReiteratesBuy → BuyGet Alert
05/08/2024Buy Now60.37%HC Wainwright & Co.
Yi Chen61%
$16 → $14MaintainsBuyGet Alert
05/08/2024Buy Now152%JMP Securities
Jonathan Wolleben72%
$24 → $22MaintainsMarket OutperformGet Alert
05/08/2024Buy Now-19.82%TD Cowen
Tara Bancroft66%
$11 → $7MaintainsHoldGet Alert
04/19/2024Buy Now83.28%HC Wainwright & Co.
Yi Chen61%
$16 → $16ReiteratesBuy → BuyGet Alert
04/16/2024Buy Now174.91%JMP Securities
Jonathan Wolleben72%
$24 → $24ReiteratesMarket Outperform → Market OutperformGet Alert
03/13/2024Buy Now174.91%JMP Securities
Jonathan Wolleben72%
$24 → $24ReiteratesMarket Outperform → Market OutperformGet Alert
03/13/2024Buy Now71.82%HC Wainwright & Co.
Yi Chen61%
$12 → $15MaintainsBuyGet Alert
03/12/2024Buy Now26%TD Cowen
Tara Bancroft66%
$8 → $11MaintainsMarket PerformGet Alert
03/12/2024Buy Now174.91%JMP Securities
Jonathan Wolleben72%
$12 → $24MaintainsMarket OutperformGet Alert
02/26/2024Buy Now71.82%Piper Sandler
Joseph Catanzaro46%
$10 → $15MaintainsOverweightGet Alert
02/14/2024Buy Now37.46%HC Wainwright & Co.
Yi Chen61%
$12 → $12ReiteratesBuy → BuyGet Alert
02/09/2024Buy Now71.82%B of A Securities
Tazeen Ahmad56%
→ $15Initiates → BuyGet Alert
10/04/2023Buy Now37.46%HC Wainwright & Co.
Yi Chen61%
→ $12ReiteratesBuy → BuyGet Alert
09/14/2023Buy Now106.19%Baird
Colleen Kusy36%
→ $18ReiteratesOutperform → OutperformGet Alert
08/08/2023Buy Now37.46%HC Wainwright & Co.
Yi Chen61%
→ $12ReiteratesBuy → BuyGet Alert
06/13/2023Buy Now37.46%Baird
Colleen Kusy36%
$10 → $12MaintainsOutperformGet Alert
06/13/2023Buy Now37.46%JMP Securities
Jonathan Wolleben72%
→ $12Reiterates → Market OutperformGet Alert
06/13/2023Buy Now37.46%HC Wainwright & Co.
Yi Chen61%
$10 → $12MaintainsBuyGet Alert
06/08/2023Buy Now14.55%HC Wainwright & Co.
Yi Chen61%
→ $10ReiteratesBuy → BuyGet Alert
05/09/2023Buy Now14.55%HC Wainwright & Co.
Yi Chen61%
$11 → $10MaintainsBuyGet Alert
05/09/2023Buy Now37.46%JMP Securities
Jonathan Wolleben72%
$11 → $12MaintainsOutperformGet Alert
04/21/2023Buy Now106.19%Baird
Colleen Kusy36%
→ $18Initiates → OutperformGet Alert
03/07/2023Buy Now26%HC Wainwright & Co.
Yi Chen61%
→ $11Reiterates → BuyGet Alert
03/07/2023Buy Now26%JMP Securities
Jonathan Wolleben72%
$12 → $11MaintainsMarket OutperformGet Alert
02/14/2023Buy Now26%HC Wainwright & Co.
Yi Chen61%
$9 → $11MaintainsBuyGet Alert
02/13/2023Buy Now37.46%JMP Securities
Jonathan Wolleben72%
→ $12Reiterates → Market OutperformGet Alert
01/09/2023Buy Now37.46%JMP Securities
Jonathan Wolleben72%
$25 → $12MaintainsMarket OutperformGet Alert
11/08/2022Buy Now3.09%HC Wainwright & Co.
Yi Chen61%
$10 → $9MaintainsBuyGet Alert
11/08/2022Buy Now60.37%Raymond James
Dane Leone45%
$29 → $14MaintainsStrong BuyGet Alert
08/09/2022Buy Now186.37%JMP Securities
Jonathan Wolleben72%
$20 → $25MaintainsMarket OutperformGet Alert

FAQ

Q

What is the target price for Ocular Therapeutix (OCUL) stock?

A

The latest price target for Ocular Therapeutix (NASDAQ:OCUL) was reported by HC Wainwright & Co. on May 29, 2025. The analyst firm set a price target for $15.00 expecting OCUL to rise to within 12 months (a possible 71.82% upside). 16 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Ocular Therapeutix (OCUL)?

A

The latest analyst rating for Ocular Therapeutix (NASDAQ:OCUL) was provided by HC Wainwright & Co., and Ocular Therapeutix reiterated their buy rating.

Q

When was the last upgrade for Ocular Therapeutix (OCUL)?

A

The last upgrade for Ocular Therapeutix Inc happened on June 20, 2024 when TD Cowen raised their price target to $11. TD Cowen previously had a hold for Ocular Therapeutix Inc.

Q

When was the last downgrade for Ocular Therapeutix (OCUL)?

A

There is no last downgrade for Ocular Therapeutix.

Q

When is the next analyst rating going to be posted or updated for Ocular Therapeutix (OCUL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocular Therapeutix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocular Therapeutix was filed on May 29, 2025 so you should expect the next rating to be made available sometime around May 29, 2026.

Q

Is the Analyst Rating Ocular Therapeutix (OCUL) correct?

A

While ratings are subjective and will change, the latest Ocular Therapeutix (OCUL) rating was a reiterated with a price target of $15.00 to $15.00. The current price Ocular Therapeutix (OCUL) is trading at is $8.73, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch